Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabien Calvo

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Cancer Chemotherapy and Pharmacology|August 3, 2005
Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cellsMaria Serova, Fabien Calvo, François Lokiec, et al.
Oncogene|December 5, 2003
SIAH-1 interacts with CtIP and promotes its degradation by the proteasome pathwayAntonia Germani, Audrey Prabel, Samia Mourah, et al.
The American Journal of Pathology|January 6, 2005
Differential expression of extracellular matrix metalloproteinase inducer (CD147) in normal and ulcerated corneas: role in epithelio-stromal interactions and matrix metalloproteinase inductionEric E Gabison, Samia Mourah, Emanuelle Steinfels, et al.
Cancer Research|January 11, 2007
Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasionCathy Quemener, Eric E Gabison, Benyoussef Naïmi, et al.
Cancer Immunology, Immunotherapy : CII|June 22, 2010
Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vgamma9Vdelta2 T lymphocyte agonist in patients with solid tumorsJaafar Bennouna, Vincent Levy, Hélène Sicard, et al.
Molecular Cancer Therapeutics|April 17, 2008
Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cellsMaria Serova, Aïda Ghoul, Karim A Benhadji, et al.
Plos One|July 14, 2010
Zebrafish ProVEGF-C expression, proteolytic processing and inhibitory effect of unprocessed ProVEGF-C during fin regenerationAbdel-Majid Khatib, Rachid Lahlil, Nathalie Scamuffa, et al.
Blood|October 20, 2009
EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2alpha-mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2Faten Bougatef, Cathy Quemener, Sabrina Kellouche, et al.
The International Journal of Biological Markers|June 15, 2010
Identification of a novel biomarker signature associated with risk for bone metastasis in patients with renal cell carcinomaBernard Paule, Emmanuelle Deslandes, St Phane E Le Mouel, et al.
European Journal of Cancer (Oxford, England : 1990)|September 22, 2018
Cancer Core Europe: A European cancer research alliance realizing a research infrastructure with critical mass and programmatic approach to cure cancer in the 21st centuryFabien Calvo, Giovanni Apolone, Michael Baumann, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Cancer Chemotherapy and Pharmacology|August 3, 2005
Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cellsMaria Serova, Fabien Calvo, François Lokiec, et al.
Oncogene|December 5, 2003
SIAH-1 interacts with CtIP and promotes its degradation by the proteasome pathwayAntonia Germani, Audrey Prabel, Samia Mourah, et al.
The American Journal of Pathology|January 6, 2005
Differential expression of extracellular matrix metalloproteinase inducer (CD147) in normal and ulcerated corneas: role in epithelio-stromal interactions and matrix metalloproteinase inductionEric E Gabison, Samia Mourah, Emanuelle Steinfels, et al.
Cancer Research|January 11, 2007
Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasionCathy Quemener, Eric E Gabison, Benyoussef Naïmi, et al.
Cancer Immunology, Immunotherapy : CII|June 22, 2010
Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vgamma9Vdelta2 T lymphocyte agonist in patients with solid tumorsJaafar Bennouna, Vincent Levy, Hélène Sicard, et al.
Molecular Cancer Therapeutics|April 17, 2008
Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cellsMaria Serova, Aïda Ghoul, Karim A Benhadji, et al.
Plos One|July 14, 2010
Zebrafish ProVEGF-C expression, proteolytic processing and inhibitory effect of unprocessed ProVEGF-C during fin regenerationAbdel-Majid Khatib, Rachid Lahlil, Nathalie Scamuffa, et al.
Blood|October 20, 2009
EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2alpha-mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2Faten Bougatef, Cathy Quemener, Sabrina Kellouche, et al.
The International Journal of Biological Markers|June 15, 2010
Identification of a novel biomarker signature associated with risk for bone metastasis in patients with renal cell carcinomaBernard Paule, Emmanuelle Deslandes, St Phane E Le Mouel, et al.
European Journal of Cancer (Oxford, England : 1990)|September 22, 2018
Cancer Core Europe: A European cancer research alliance realizing a research infrastructure with critical mass and programmatic approach to cure cancer in the 21st centuryFabien Calvo, Giovanni Apolone, Michael Baumann, et al.
Pageof 9